Related references
Note: Only part of the references are listed.AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells
Yan Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling
Xin Yin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Regulation of NANOG in Cancer Cells
Shuai Gong et al.
MOLECULAR CARCINOGENESIS (2015)
Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro
Xu Chen et al.
TUMOR BIOLOGY (2015)
ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma
Man Tong et al.
STEM CELL REPORTS (2015)
Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression
Xuejun Yang et al.
TUMOR BIOLOGY (2015)
Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression
Shu-Ching Hsieh et al.
AMINO ACIDS (2014)
AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells
Brice Sid et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
Xiaona Liu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Effect of basic fibroblast growth factor on pluripotent marker expression and colony forming unit capacity of stem cells isolated from human exfoliated deciduous teeth
Waleerat Sukarawan et al.
ODONTOLOGY (2014)
Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
Xinbing Sui et al.
PLOS ONE (2014)
Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model
Gaoya Xu et al.
ONCOTARGET (2014)
Lipocalin-2 Negatively Modulates the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Through the Epidermal Growth Factor (TGF-beta1)/Lcn2/Twist1 Pathway
Yun-Peng Wang et al.
HEPATOLOGY (2013)
NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway
Chun Sun et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
Shanmiao Gou et al.
PLOS ONE (2013)
Implication of transcriptional repression in compound C-induced apoptosis in cancer cells
R. Y. Dai et al.
CELL DEATH & DISEASE (2013)
AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition
Jang Han Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
Juanjuan Shan et al.
HEPATOLOGY (2012)
Hispidin Analogue Davallialactone Attenuates Carbon Tetrachloride-Induced Hepatotoxicity in Mice
Prabodh Risal et al.
JOURNAL OF NATURAL PRODUCTS (2012)
5-Aminoimidazole-4-carboxyamide Ribonucleoside Induces G1/S Arrest and Nanog Downregulation via p53 and Enhances Erythroid Differentiation
Hee-Don Chae et al.
STEM CELLS (2012)
Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153
N. Wu et al.
NEOPLASMA (2011)
Phosphoproteomic Analysis of Human Embryonic Stem Cells
Laurence M. Brill et al.
CELL STEM CELL (2009)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases
Marie A. Bogoyevitch et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase
R Rattan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma
LL Guo et al.
LIFE SCIENCES (2005)
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
I Chambers et al.
CELL (2003)
Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells
D Meisse et al.
FEBS LETTERS (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
